ArticleLife (Basel, Switzerland)2024

Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study).

Hamid Ehsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.